Workshop Day

Monday 29th January, 2024

9:00 am Registration & Morning Coffee

9:30 am Workshop A – Regulatory Workshop

Unravelling the Regulatory Roadmap for Allogeneic Products to Pave the Route to Commercial Success


Having a clear understanding of current regulations for preclinical, clinical and CMC

is essential in the progression of your allogeneic products and therapies. In this

regulatory workshop hear about new regulations and changes from experts from

regulatory bodies across Europe and have your burning questions answered by these

key players.

This workshop will cover:

• Recent guideline changes in Europe to inform on clinical trial design and data


• How new cell and gene therapy comparability guidelines may impact process

changes during development

• Global differences in data requirements for the transition from preclinical to clinical


12:30 pm Lunch Break & Networking

1:30 pm Workshop B- Investment Workshop

Fuelling the Research Revolution: Strategies for Funding Success


A major bottleneck for much of the most innovative and impactful research is a lack

of adequate funding. In this investor workshop hear from decision makers in venture

capital, advanced therapy investment and business development leader in big

pharma. Hear what they are looking out for in future investments to consolidate your

financial strategy going forward

This workshop will cover:

• Key criteria investors use to assess funding potential of early-stage allogeneic


• Innovative technologies and clinical data that can catalyse wider investment into the


• Deal structures and licensing models commonly used for partnering on allogeneic


4:40 pm End of Pre-Conference Workshop Day